Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages 393-397

  Schulman, S ^a   Melinyshyn, A ^a   Ennis, D ^a   Rudd Scott, L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

anticoagulants; medication therapy management; outpatients; warfarin

Indexed keywords

AMOXICILLIN; LEVOFLOXACIN; WARFARIN;

ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTERVIEW; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TELEPHONE; TREATMENT DURATION;

ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; WARFARIN;

EID: 77951667012     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.07.006     Document Type: Article

References (15)

1. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., and Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 160S-198S
2. Crowther M.A., Ageno W., Garcia D., Wang L., Witt D.M., Clark N.P., et al. Oral vitamin K vs. placebo in the correction of excessively anticoagulated patients on warfarin: results of a randomized, controlled trial. Ann Intern Med 150 (2009) 293-300
3. Hylek E.M., Chang Y.C., Skates S.J., Hughes R.A., and Singer D.E. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 160 (2000) 1612-1617
4. Gunneman T., Ruybalid R.L., Jacobson A.K., Snell B., Zucker M.L., LaDuca F.M., et al. Frequent prothrombin time testing reduces inappropriate warfarin dose changes. Thromb Haemost 82 (1999) 676 (suppl) (abstract)
5. Gage B.F., Fihn S.D., and White R.H. Management and dosing of warfarin therapy. Am J Med 109 (2000) 481-488
6. Waterman A.D., Milligan P.E., Banet G.A., Gatchel S.K., and Gage B.F. Establishing and running an effective telephone-based anticoagulation service. J Vasc Nurs 19 (2001) 126-132
7. Britt R.P., James A.H., Raskino C.L., and Thompson S.G. Factors affecting the precision of warfarin treatment. J Clin Pathol 45 (1992) 1003-1006
8. Dalere G.M., Coleman R.W., and Lum B.L. A graphic nomogram for warfarin dosage adjustment. Pharmacotherapy 19 (1999) 461-467
9. Horton J.D., and Bushwick B.M. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Phys 59 (1999) 635-646
10. Ryan P.J., Gilbert M., and Rose P.E. Computer control of anticoagulant dose for therapeutic management. Bmj 299 (1989) 1207-1209
11. Rose A.J., Ozonoff A., Berlowitz D.R., Henault L.E., and Hylek E.M. Warfarin dose management affects INR control. J Thromb Haemost 7 (2009) 94-101
12. Schulman S. A preliminary study on the feasibility of extending the interval between prothrombin time tests for patients on warfarin therapy. Haematologica 90 (2005) 132 (abstr 0336)
13. Salas M., Hofman A., and Stricker B.H.C. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 149 (1999)
14. Banet G.A., Waterman A.D., Milligan P.E., Gatchel S.K., and Gage B.F. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio. Chest 123 (2003) 499-503
15. Clark N.P., Witt D.M., Delate T., Trapp M., Garcia D., Ageno W., et al. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacother 8 (2008) 960-967